April 17, 2014 8:56 AM ET

Biotechnology

Company Overview of Permeon Biologics, Inc.

Company Overview

Permeon Biologics, Inc. develops a panel of human proteins that exhibit potent activity for intracellular biologics in vivo and create active therapeutic agents with potent intracellular activity without cytotoxicity. The company offers Intraphilin Technology Platform to enable intracellular biologics as therapeutic drugs. Its Intraphilin Technology Platform enables intracellular biologics based on identifying naturally occurring human supercharged proteins with an ability to activate cell uptake and permeate to function inside cell cytoplasm and other intracellular compartments to unlock a spectrum of intracellular disease targets and deliver breakthrough therapies for previously untreatabl...

One Kendall Square

Building 1400W

Suite 14203

Cambridge, MA 02139

United States

Founded in 2008

Phone:

617-945-7780

Fax:

617-868-1115

Key Executives for Permeon Biologics, Inc.

President
Age: 56
Scientific Advisory Board Chairman
Chief Executive Officer of Permeon Biologics
Board Observer
Age: 49
Director of Permeon Biologics
Age: 71
Compensation as of Fiscal Year 2013.

Similar Private Companies By Industry

Company Name Region
Tidal Air, Inc. United States
Armed, L.L.C. United States
CRL Transaction Co., Inc. United States
Nucleonics, Inc. United States
Hanson Technologies, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Permeon Biologics, Inc., please visit www.permeonbio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.